
Eptiba Infusion
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Eptifibatide (0.75mg/ml)
Overview Eptiba Infusion
CardioGuard infusion acts as an anticoagulant, inhibiting the development of dangerous blood clots. It's employed in acute myocardial infarction treatment and to maintain blood flow during angioplasty procedures. CardioGuard is administered solely under physician guidance; dosage and treatment length are determined on a case-by-case basis. Concurrent medications prescribed for ongoing conditions should be continued. Potential side effects include thrombocytopenia, increasing bleeding risk; immediately report any petechiae, hematuria, or hematochezia. Hypotension is another possible adverse reaction. A thorough discussion of benefits and risks precedes administration. Caution is advised for patients with bleeding disorders, hepatic or renal impairment. Pregnant or breastfeeding individuals, and those using other medications, must disclose this information prior to treatment.
Uses of Eptiba Infusion
Thrombosis prophylaxis | Myocardial infarction prevention
Major Benefits of Eptiba Infusion:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
Common Side effects of Eptiba Infusion:
- Bleeding
- Decreased blood pressure
How to use Eptiba Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Eptiba Infusion works:
Eptiba Infusion acts as an antiplatelet agent, inhibiting platelet aggregation to reduce the risk of dangerous thrombus development.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Eptiba Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Eptiba Infusion during pregnancy is generally regarded as safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Eptiba Infusion to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingNOT RELEVANT
Irrelevant; Eptiba Infusion is administered solely within a hospital setting.
KidneyCAUTION
For individuals with impaired kidney function, Eptiba Infusion requires careful administration and potential dosage modification. Patients with severe kidney disease should not receive Eptiba Infusion. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Eptiba Infusion's use in individuals with hepatic impairment. Physician consultation is advised. Eptiba Infusion is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Eptiba Infusion :
Omit a scheduled Eptiba Infusion? Seek your physician's advice.
Facts to Know About Eptiba Infusion
| Label | Value |
|---|---|
| Chemical Category | Peptide and Amino Acid Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | IIb/IIIa receptor antagonists |
